Effect of SGLT-2 inhibitors as an add-on therapy to metformin on P wave indices and atrial electromechanics in type 2 diabetes mellitus patients.
Murat ZiyrekEsra DonmezSevgi OzcanMustafa DuranHüseyin TezcanOrhan İnceEmrah ÖzdemirIrfan SahinErtuğrul OkuyanPublished in: Pacing and clinical electrophysiology : PACE (2023)
SGLT-2 inhibitors as an add-on therapy to metformin were shown to significantly improve P wave indices and atrial electromechanics in type 2 DM patients as early as the 3rd month of treatment. It was thought that this may be one of the underlying mechanisms of the decrease in the frequency of AF with the use of SGLT2 inhibitors.